Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
-

-

-
-
-
-

-

 
WKN: A2QQRS / Symbol: SNSS / Name: Viracta Therapeutics Inc. / Stock / Biotechnology & Medical Research / Small Cap /

Viracta Therapeutics Inc. Stock

Our community identified positive and negative aspects for Viracta Therapeutics Inc. stock for the coming years. 2 users see the criterium "Worthwhile Investment for the next years" as a plus for the Viracta Therapeutics Inc. stock. On the other hand our users think that "Unique positioning" could be a problem in the future.

Pros and Cons of Viracta Therapeutics Inc. in the next few years

Pros
?
M***** P*******
?
W********* I********* f** t** n*** y****
?
B****
Cons
?
C******** o* t** e**********
?
S********** s********
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Viracta Therapeutics Inc. vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Viracta Therapeutics Inc. - - - - - - -
Ardelyx Inc. -1.150% 4.938% 4.547% -6.506% 1.873% 194.138% -2.880%
Krystal Biotech 0.800% 8.522% 17.592% 14.742% 32.194% 183.380% -
Evolus Inc 0.880% -1.724% -5.785% -51.695% -45.714% -12.977% 91.019%